Regentis Biomaterials H1 EPS $(0.44) Up From $(1.17) YoY
Regentis Biomaterials (AMEX:RGNT) reported quarterly losses of $(0.44) per share. This is a 62.39 percent increase over losses of $(1.17) per share from the same period last year.
Regentis lost less money per share this year than last year, which means the company is getting closer to being healthy. When a losing company loses less money over time, that is something to watch as a hopeful sign.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.